To better understand the stage(s) of differentiation reached by B-type chronic lymphocytic leukemia (B-CLL) cells and to gain insight into the potential role of antigenic stimulation in the development and diversification of these cells, we analyzed the rearranged VH genes expressed by 83 B-CLL cells (64 IgM+ and 19 non-IgM+). Our results confirm and extend the observations of a bias in the use of certain VH, D, and JH genes among B-CLL cells. In addition, they indicate that the VH genes of approximately 50% of the IgM+ B-CLL cells and approximately 75% of the non-IgM+ B-CLL cells can exhibit somatic mutations. The presence of mutation varies according to the VH family expressed by the B-CLL cell (VH3 expressers displaying more mutation than VH1 and VH4 expressers). In addition, the extent of mutation can be sizeable with approximately 32% of the IgM+ cases and approximately 68% of the non-IgM+ cases differing by > 5% from the most similar germline gene. Approximately 20% of the mutated VH genes display replacement mutations in a pattern consistent with antigen selection. However, CDR3 characteristics (D and JH gene use and association and HCDR3 length, composition, and charge) suggest that selection for distinct B cell receptors (BCR) occurs in many more B-CLL cells. Based on these data, we suggest three prototypic BCR, representing the VH genes most frequently encountered in our study. These data suggest that many B-CLL cells have been previously stimulated, placing them in the "experienced" or "memory" CD5(+) B cell subset.
F Fais, F Ghiotto, S Hashimoto, B Sellars, A Valetto, S L Allen, P Schulman, V P Vinciguerra, K Rai, L Z Rassenti, T J Kipps, G Dighiero, H W Schroeder Jr, M Ferrarini, N Chiorazzi
Title and authors | Publication | Year |
---|---|---|
Stereotypical chronic lymphocytic leukemia B-cell receptors recognize survival promoting antigens on stromal cells
M Binder, B Léchenne, R Ummanni, C Scharf, S Balabanov, M Trusch, H Schlüter, I Braren, E Spillner, M Trepel |
PloS one | 2010 |
Distinct gene expression profiles in subsets of chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors
M Marincevic, M Mansouri, M Kanduri, A Isaksson, H Göransson, KE Smedby, J Jurlander, G Juliusson, F Davi, K Stamatopoulos, R Rosenquist |
Haematologica | 2010 |
High-density screening reveals a different spectrum of genomic aberrations in chronic lymphocytic leukemia patients with 'stereotyped' IGHV3-21 and IGHV4-34 B-cell receptors
M Marincevic, N Cahill, R Gunnarsson, A Isaksson, M Mansouri, H Göransson, M Rasmussen, M Jansson, F Ryan, K Karlsson, HO Adami, F Davi, J Jurlander, G Juliusson, K Stamatopoulos, R Rosenquist |
Haematologica | 2010 |
Intraclonal diversification of immunoglobulin light chains in a subset of chronic lymphocytic leukemia alludes to antigen-driven clonal evolution
E Kostareli, LA Sutton, A Hadzidimitriou, N Darzentas, A Kouvatsi, A Tsaftaris, A Anagnostopoulos, R Rosenquist, K Stamatopoulos |
Leukemia | 2010 |
Chronic lymphocytic leukaemia: a disease of activated monoclonal B cells
RN Damle, C Calissano, N Chiorazzi |
Best Practice & Research Clinical Haematology | 2010 |
Dichotomy in NF-kappaB signaling and chemoresistance in immunoglobulin variable heavy-chain-mutated versus unmutated CLL cells upon CD40/TLR9 triggering
JM Tromp, SH Tonino, JA Elias, A Jaspers, DM Luijks, AP Kater, RA van Lier, MH van Oers, E Eldering |
Oncogene | 2010 |
B-cell receptor epitope recognition correlates with the clinical course of chronic lymphocytic leukemia
M Binder, F Müller, A Jackst, B Léchenne, M Pantic, U Bacher, C Eulenburg, H Veelken, R Mertelsmann, R Pasqualini, W Arap, M Trepel |
Cancer | 2010 |
Oligoclonality, impaired class switch and B-cell memory responses in WHIM syndrome
PJ Guire, C Cunningham-Rundles, H Ochs, GA Diaz |
Clinical Immunology | 2010 |
Single-Agent Lenalidomide in the Treatment of Previously Untreated Chronic Lymphocytic Leukemia
CI Chen, PL Bergsagel, H Paul, W Xu, A Lau, N Dave, V Kukreti, E Wei, C Leung-Hagesteijn, ZH Li, J Brandwein, M Pantoja, J Johnston, S Gibson, T Hernandez, D Spaner, S Trudel |
Journal of Clinical Oncology | 2010 |
Primary cutaneous B-cell lymphoma is associated with somatically hypermutated immunoglobulin variable genes and frequent use of VH1-69 and VH4-59 segments
M Perez, A Pacchiarotti, M Frontani, E Pescarmona, E Caprini, GA Lombardo, G Russo, T Faraggiana |
British Journal of Dermatology | 2010 |
Molecular and clinical features of chronic lymphocytic leukemia with stereotyped B-cell receptors in a Ukrainian cohort
N Bilous, R Bomben, MD Bo, D Capello, F Forconi, L Laurenti, F Bertoni, DG Efremov, R Marasca, GD Poeta, Z Martina, I Kryachouk, I Dyagil, G Gaidano, A Chumak, V Gattei, I Abramenko |
Leukemia & Lymphoma | 2010 |
Antigens in chronic lymphocytic leukemia—Implications for cell origin and leukemogenesis
A Rosén, F Murray, C Evaldsson, R Rosenquist |
Seminars in Cancer Biology | 2010 |
Immunohistochemical detection of ZAP70 in chronic lymphocytic leukemia predicts immunoglobulin heavy chain gene mutation status and time to progression
JH Admirand, RJ Knoblock, KR Coombes, C Tam, EJ Schlette, WG Wierda, A Ferrajoli, S O'Brien, MJ Keating, R Luthra, LJ Medeiros, LV Abruzzo |
Modern Pathology | 2010 |
Polymerase chain reaction (PCR) detection of B cell clonality in Sjögren's syndrome patients: a diagnostic tool of clonal expansion
LM Guzmán, D Castillo, SO Aguilera |
Clinical & Experimental Immunology | 2010 |
Immunoglobulin heavy chain V-D-J gene rearrangement and mutational status in Uruguayan patients with chronic lymphocytic leukemia
S Bianchi, P Moreno, AI Landoni, H Naya, P Oppezzo, G Dighiero, R Gabús, O Pritsch |
Leukemia & Lymphoma | 2010 |
Activation-induced cytidine deaminase splicing patterns in chronic lymphocytic leukemia
F Marantidou, A Dagklis, E Stalika, P Korkolopoulou, A Saetta, A Anagnostopoulos, N Laoutaris, K Stamatopoulos, C Belessi, Z Scouras, E Patsouris |
Blood Cells, Molecules, and Diseases | 2010 |
Chronic lymphocytic leukemia in a Japanese population: varied immunophenotypic profile, distinctive usage of frequently mutatedIGHgene, and indolent clinical behavior
J Tomomatsu, Y Isobe, K Oshimi, Y Tabe, K Ishii, M Noguchi, T Hirano, N Komatsu, K Sugimoto |
Leukemia & Lymphoma | 2010 |
Telomere/telomerase interplay in virus-driven and virus-independent lymphomagenesis: Pathogenic and clinical implications
R Dolcetti, AD Rossi |
Medicinal Research Reviews | 2010 |
Genetic variation and risk of chronic lymphocytic leukaemia
D Crowther-Swanepoel, RS Houlston |
Seminars in Cancer Biology | 2010 |
New insights into the pathogenesis of chronic lymphocytic leukemia
U Klein, R Dalla-Favera |
Seminars in Cancer Biology | 2010 |
Moving from prognostic to predictive factors in chronic lymphocytic leukaemia (CLL)
T Zenz, S Fröhling, D Mertens, H Döhner, S Stilgenbauer |
Best Practice & Research Clinical Haematology | 2010 |
The B cell antigen receptor in atypical chronic lymphocytic leukemia with t(14;19)(q32;q13) demonstrates remarkable stereotypy
CD Schweighofer, YO Huh, R Luthra, RL Sargent, RP Ketterling, RA Knudson, LL Barron, LJ Medeiros, MJ Keating, LV Abruzzo |
International Journal of Cancer | 2010 |
Regulatory T cells predict the time to initial treatment in early stage chronic lymphocytic leukemia
L Weiss, T Melchardt, A Egle, C Grabmer, R Greil, I Tinhofer |
Cancer | 2010 |
Novel Insights into the Biology of CLL
MC Lanasa |
Hematology | 2010 |
Biologic and clinical significance of molecular profiling in Chronic Lymphocytic Leukemia
T Butler, JG Gribben |
Blood Reviews | 2010 |
NF-κB as a therapeutic target in chronic lymphocytic leukemia
M Lopez-Guerra, D Colomer |
Expert Opinion on Therapeutic Targets | 2010 |
Stereotypical Chronic Lymphocytic Leukemia B-Cell Receptors Recognize Survival Promoting Antigens on Stromal Cells
M Binder, B Léchenne, R Ummanni, C Scharf, S Balabanov, M Trusch, H Schlüter, I Braren, E Spillner, M Trepel, D Gullberg |
PloS one | 2010 |
MicroRNAs in Cancer Translational Research
WC Cho |
2010 | |
Molecular Pathology of Hematolymphoid Diseases
CH Dunphy |
2010 | |
Cancer Management in Man: Chemotherapy, Biological Therapy, Hyperthermia and Supporting Measures
BR Minev |
2010 | |
Mechanisms of Oncogenesis
D Coppola |
2010 |